Richard Friedman to Thiophenes
This is a "connection" page, showing publications Richard Friedman has written about Thiophenes.
Connection Strength
0.970
-
Novel oral anticoagulants for VTE prevention in orthopedic surgery: overview of phase 3 trials. Orthopedics. 2011 Oct; 34(10):795-804.
Score: 0.373
-
Clinical experience with novel oral anticoagulants for thromboprophylaxis after elective hip and knee arthroplasty. Arterioscler Thromb Vasc Biol. 2015 Apr; 35(4):771-8.
Score: 0.118
-
Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty. Vasc Health Risk Manag. 2014; 10:157-67.
Score: 0.111
-
Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty. Thromb Res. 2012 Aug; 130(2):147-51.
Score: 0.095
-
Economic impact of venous thromboembolism after hip and knee arthroplasty: potential impact of rivaroxaban. Expert Rev Pharmacoecon Outcomes Res. 2011 Jun; 11(3):299-306.
Score: 0.091
-
New oral anticoagulants for venous thromboembolism prophylaxis in orthopaedic surgery. Instr Course Lect. 2011; 60:291-300.
Score: 0.089
-
Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med. 2008 Jun 26; 358(26):2765-75.
Score: 0.074
-
Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Relat Res. 2008 Aug; 466(8):2009-11; author reply 2012-4.
Score: 0.019